Prevalence of asthma among the adult general population of five Middle Eastern countries: results of the SNAPSHOT program

Simple item page
dc.contributor.authorAydin, Ömür
dc.contributor.departmentTıp Fakültesitr_TR
dc.date.accessioned2020-12-30T12:56:38Z
dc.date.available2020-12-30T12:56:38Z
dc.date.issued2018
dc.description.abstractBackground: Asthma is a common chronic respiratory disease leading to morbidity, mortality and impaired quality of life worldwide. Information on asthma prevalence in the Middle East is fragmented and relatively out-dated. The SNAPSHOT program was conducted to obtain updated information. Methods: SNAPSHOT is a cross-sectional epidemiological program carried out in five Middle Eastern countries (Egypt, Turkey, Kuwait, Saudi Arabia, and the United Arab Emirates, the latter three grouped into a Gulf cluster) to collect data on asthma, allergic rhinitis, benign prostatic hyperplasia and bipolar disorder. The survey was carried out by telephone in a random sample of the adult general population with quotas defined according to country demographics. The analysis presented in this paper focuses on asthma. Subjects were screened for asthma based on criteria from the global Asthma Insights and Reality studies. Current prevalence (last 12 months) was estimated. Multivariate logistic regression analyses were used to investigate risk factors related to asthma and the association with allergic rhinitis and other co-morbidities. Quality of life was assessed using the three-level EQ-5D questionnaire. Results: 2124 out of the 33,486 subjects enrolled in the SNAPSHOT program fulfilled the criteria for asthma. The adjusted prevalence of asthma ranged from 4.4% [95% CI: 4.0-4.8%] in Turkey, to 6.7% [95% CI: 6.2-7.2%] in Egypt and 7.6% [95% CI: 7.1-8.0%] in the Gulf cluster. Prevalence was higher (p < 0.0001) in women than men and increased with age (p < 0.0001). Co-morbidities occurred more frequently in asthma subjects compared to the non-asthma population (38% vs. 15% p < 0.0001). Subjects with asthma reported a lower (p < 0.0001) EQ-VAS score (68.2 ± 22.9) compared to the general population (78.1 ± 17.5). The risk factors associated with asthma were age, gender, country, and certain co-morbidities, namely respiratory, cardiovascular, gastrointestinal, nervous, and neurological diseases. Conclusion: The observed adjusted prevalence of asthma in the Middle East ranges from 4.4% to 7.6%, which is comparatively lower than the reported prevalence in Europe and North America. Asthma has a negative impact on quality of life, and is associated with high levels of co-morbid diseases, indicating a need for physicians to check for co-morbidities and ensure they are managed correctly in all asthma patients.tr_TR
dc.description.indexPubmed
dc.identifier.endpage14tr_TR
dc.identifier.issue68tr_TR
dc.identifier.startpage1tr_TR
dc.identifier.urihttps://doi.org/10.1186/s12890-018-0621-9tr_TR
dc.identifier.urihttp://hdl.handle.net/20.500.12575/72617
dc.identifier.volume18tr_TR
dc.language.isoentr_TR
dc.relation.isversionof10.1186/s12890-018-0621-9tr_TR
dc.relation.journalBMC Pulm Med .tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıtr_TR
dc.subjectAsthmatr_TR
dc.subjectCo-morbiditytr_TR
dc.subjectMiddle Easttr_TR
dc.titlePrevalence of asthma among the adult general population of five Middle Eastern countries: results of the SNAPSHOT programtr_TR
dc.typeArticletr_TR

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
12890_2018_Article_621.pdf
Size:
1.64 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.62 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Makale
PubMed İndeksli Yayınlar